Open-Label Study of AB-729, Nucleos(t)Ide Analogue and Pegylated Interferon Alfa-2a in Subjects With Chronic Hepatitis B Infection

NCT04980482 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis b

Interventions

DRUG: AB-729
DRUG: Peg-IFNα-2a

Sponsor

Arbutus Biopharma Corporation